Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and endothelin-1

1,3-dipropyl-8-cyclopentylxanthine has been researched along with endothelin-1 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E1
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E1
Fyhrquist, F; Saijonmaa, O; Törnquist, K; Vainio, M1
Guimarães, S; Moura, D; Vaz-da-Silva, MJ1
Chilian, WM; Jones, DW; Merkus, D; Nishikawa, Y; Stepp, DW1

Other Studies

5 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and endothelin-1

ArticleYear
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
    Bioorganic & medicinal chemistry, 2016, Apr-15, Volume: 24, Issue:8

    Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine

2016
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship

2017
Purinergic agonists stimulate the secretion of endothelin-1 in rat thyroid FRTL-5 cells.
    Journal of cellular physiology, 1996, Volume: 169, Issue:3

    Topics: Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Animals; Calcium; Cell Line; Cyclic AMP; Cyclic GMP; Endothelin-1; Enzyme Activation; Nitric Oxide; Protein Kinase C; Purinergic P1 Receptor Agonists; Rats; Receptors, Purinergic P1; Secretory Rate; Signal Transduction; Thyroid Gland; Xanthines

1996
Adenosine and the endothelium-dependent modulation of 3H-noradrenaline release in the canine pulmonary artery.
    Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 352, Issue:6

    Topics: Adenosine; Animals; Dogs; Electric Stimulation; Endothelin-1; Endothelium, Vascular; Female; Isotope Labeling; Male; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Potassium; Potassium Channels; Pulmonary Artery; Purinergic P1 Receptor Antagonists; Suramin; Tetraethylammonium; Tetraethylammonium Compounds; Tritium; Xanthines

1995
Adenosine preconditions against endothelin-induced constriction of coronary arterioles.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6

    Topics: Adenosine; Animals; Arterioles; Caffeine; Coronary Circulation; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Microcirculation; Purinergic P1 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents; Xanthines

2000